Pharmacology of neurotrophic factors

Annual Review of Pharmacology and Toxicology

Volumn 37, Issue , 1997, Pages 239-267

  Hefti, Franz ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

nerve growth factor; neurodegeneration; neuropathy; trk receptors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CEREBROVASCULAR ACCIDENT; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY;

EID: 0030928225     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.37.1.239     Document Type: Review

References (229)

1. Levi-Montalcini R. 1975. NGF: An uncharted route. In The Neurosciences: Paths of Discovery, ed. FG Wooten, JP Swazey, GAdelman. Cambridge, MA: MIT Press
2. Barde YA. 1996. The physiology of neurotrophins. Annu. Rev. Neurosci. 19:289-317
3. Ebendal T. 1992. Functional and evolution in the NGF family and its receptors. J. Neurosci. Res. 32:461-70
4. Chao MV. 1992. Neurotrophic receptors: a window into neuronal differentiation. Neuron 9:583-93
5. Barbacid M. 1995. Neurotrophic factors and their receptors. Curr: Opin. Cell Biol. 7:148-55
6. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhäuser N, Böhm-Matthaei R, et al. 1996. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272:542
7. Rabizadeh S, Oh J, Zhong L-T, Yang J, Bitler CM, et al. 1993. Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-48
8. Barbin G, Selak I, Manthorpe M, Varon S. 1984. Use of central neuronal cultures for the detection of neuronotrophic agents. Neuroscience 12:33-43
9. Lin L-FH, Mismer D, Lile JD, Armes LG, Butler ET III, et al. 1989. Purification, cloning, and expression of ciliary neurotrophic factor (CNTF). Science 246:1023-25
10. Patterson PH. 1994. Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. Proc. Natl. Acad. Sci. USA 91:7833-35
11. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, et al. 1995. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signalling complex. J. Biol. Chem. 270:10915-22
12. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, et al. 1991. The receptor for ciliary neurotrophic factor. Science 5:59
13. Ip NY, McClain J, Barrezueta NX, Aldrich TH. Pan L, et al. 1993. The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development. Neuron 10:89-102
14. Bothwell M. 1982. Insulin and somatomedin MSA promote nerve growth factor-independent neunte formation by cultured chick dorsal root ganglionic sensory neurons. J. Neurosci. Res. 8:225-31
15. Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-34
16. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, et al. 1996. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature 380:252
17. Fisher M, Meadows M-E, Do T, Weise J, Trubetskoy V, et al. 1995. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cerebral Blood Flow Metab. 15:953-59
18. Morrison RS, Keating RF, Moskal JR. 1988. Basic fibroblast growth factor and epidermal growth factor exert differential trophic effects on CNS neurons. J. Neurosci. Res. 21:71-79
19. Alexi T, Hefti F. 1993. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55:803-8
20. Winslow JW, Moran P, Valverde J, Shih A, Yuan JQ, et al. 1995. Cloning of AL-1, a ligand for an eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 14:973-81
21. Drescher U, Kremoser C, Handwerker C, Loschinger J, Noda M, Bonhoeffer F. 1995. In vitro guidance of retinal ganglion cell axons by RAGS, a 25Kda tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82:359-70
22. Cheng H-J, Nakamoto M, Bergemann A, Flanagan JC. 1995. Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell 82:371
23. Xu Q, Alldus G, Macdonald R, Wilkinson DG, Holder N. 1996. Function of the Eph-related kinase rtkl in patterning of the zebrafish forebrain. Nature 381:319
24. Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds RG. 1995. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse-Tyro 3. Cell 82:355-58
25. Holmes WE, Slowkowski MX, Akita RW, Henzel WJ, Lee J, et al. 1992. Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-08
26. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. 1993. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72:801-15
27. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, et al. 1993. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362:312-16
28. Fabri L, Nice EC, Ward LD, Maruta H, Burgess AW, Simpson RJ. 1992. Characterization of bovine heparin-binding neurotrophic factor (HBNF): assignment of disulfide bonds. Biochem. Intl. 28:1-9
29. Nakagawara A, Milbrandt J, Muramatsu T, Deuel T F, Zhao H, et al. 1995. Differential expression of pleiotrophin and mid-kine in advanced neuroblastomas. Cancer Res. 55:1792-97
30. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, et al. 1990. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparision between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:69-76
31. Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T. 1993. Trophic effect of erythropoietin and other hemotopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609:29-35
32. Thoenen H, Bandtlow C, Heumann R. 1987. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109:145-178
33. Snider WD. 1994. Functions of neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-38
34. Ernfors P, Merlio J-P, Persson H. 1992. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 4:1140-58
35. Collazo D, Takahashi H, McKay RDG. 1992. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9:643-56
36. Cohen-Cory S, Fraser SE. 1995. Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 378:192
37. Wang T, Xie KW, Lu B. 1995. Neurotrophins promote maturation of developing neuormuscular synapses. J. Neurosci. 15(7 pt 1):4796-805
38. Riddle DR, Lo DC, Katz LC. 1995. NT-4-mediated rescue of lateral geniculate neurons from effects of monocular deprivation. Nature 378:189
39. Castrén E, Pitkänen M, Sirviö J, Parsadanian A, Lindholm D, et al. 1993. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus. NeuroReport 4:895-98
40. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T. 1995. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92:8856-60
41. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365:27-32
42. DeChiara TM, Vejsada R, Poueymirou WT, Acheson A, Suri C, et al. 1995. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83:313-22
43. Hefti F. 1986. Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transactions. J. Neurosci. 6:2155-62
44. Beck KD, Irwin I, Valverde J, Brennan TJ, Langston JW, Hefti F. 1996. GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16:665-73
45. Sofroniew MV, Cooper JD, Svendsen CN, Crossman P, Ip NY, et al. 1993. Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF and NT3. J. Neurosci. 13:5263-76
46. Goodman LJ, Valverde J, Lim F, Geschwind MD, Federoff HJ, et al. 1996. Regulated release and polarised localisation of brain-derived neurotrophic factor (BDNF) in hippocampal neurons. Mol. Cell. Neurosci. 7:222-38
47. Thoenen H. 1995. Neurotrophins and neuronal plasticity. Science 270:593-98
48. Patterson SL, Grover LM, Schwartzkroin PA, Bothwell M. 1992. Neurotrophin expression in rat hippocampal slices: A stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mR-NAs. Neuron 9:1081-88
49. Bramham CR, Southard T, Sarvey JM, Herkenham M, Brady LS. 1996. Unilateral LTP triggers bilateral increases in hippocampal neurotrophin and trk receptor mRNA expression in behaving rats: evidence for interhemispheric communication. J. Comp. Neurol. 368:371-82
50. Silos-Santiago I, Greenlund LJS, Johnson EM Jr, Snider WD. 1995. Molecular genetics of neuronal survival. Curr. Opin. Neurobiol. 5:42-49
51. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. 1993. Programmed cell death and the control of cell survival: lessions from the nervous system. Science 262:695
52. Allsopp TE, Wyatt S, Paterson HF, Davies AM. 1993. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307
53. Zhong L-T, Kane DJ, Bredesen DE. 1993. BCL-2 blocks glutamate toxicity in neural cell lines. Mol. Brain Res. 19:353-55
54. Kane DJ, Sarafian TA, Anton R, Hahn H, Butler Gralla E, et al. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274
55. Farinelli SE, Greene LA. 1996. Cell cycle blockers mimosine, ciclopirox and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support. J. Neurosci. 16:1150-62
56. Nicholson DW. 1996. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotech. 14:297
57. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW. 1995. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 68:615-19
58. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. 1995. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat. Genet. 11:126
59. Rowland LP. 1987. Motor neuron diseases and amyotrophic lateral sclerosis: research progress. Trends Neurosci. 10:393-97
60. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-61
61. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu Z-S, et al. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91:8292-96
62. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, et al. 1996 Altered reactivity of superoxide dismutate in familial lateral sclerosis. Science 271:515
63. Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, et al. 1996. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39:128-31
64. Cöté F, Collard J-F, Julien J-P. 1993. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of myotrophic lateral sclerosis. Cell 73:35-46
65. Cedarbaum JM, Chapman C, Charatan M, Stambler N, Andrews L. 1995. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. Clin. Neuropharmacol. 18:515-32
66. Arakawa Y, Sendtner M, Thoenen H. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10:3507-15
67. Sendtner M, Stockli KA, Thoenen H. 1992. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J. Cell Biol 118:139-48
68. Sendtner M, Kreutzberg GW, Thoenen H. 1990. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440-49
69. Oppenheim RW, Prevette D, Qin-Wei Y, Collins F, MacDonald J. 1991. Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251:1616-18
70. Apfel SC, Arezzo JC, Moran M, Kessler JA. 1993. Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheral nerves in vivo. Brain Res. 604:1-6
71. Sendtner M, Schmalbruch H, Stockli K A, Carroll P, Kreutzberg G W, Thoenen H. 1992. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358:502-5
72. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T. 1994. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7:79-84
73. Dittrich F, Thoenen H, Sendtner, M. 1994. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat Ann. Neurol. 35:151-63
74. Cedarbaum JM, DiStefano PS, Lakings DB, Lindsay RM. 1996. Re: pharmacokinetics and pharmacodynamics of rHC-NTF in rodents. Ann. Neurol. 39:552-53
75. Sjoberg J, Kanje M. 1989. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res. 485:102-8
76. Near SL, Whalen LR, Miller JA, Nishii DN. 1992. Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. USA 89:11716-20
77. Contreras PC, Steffler C, Yu E, Callison K, Stong D, Vaught JL. 1995. Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush. J. Pharmacol. Exp. Ther. 27:1443-49
78. Ishii D. 1989. Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis. Proc. Natl. Acad. Sci. USA 86:2898-902
79. Ang LC, Bhaumick B, Munoz DG, Sass J, Juurlink BHJ. 1992. Effects of astrocytes insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J. Neurol. Sci. 109:168-172
80. Gehrmann J, Yao DL, Bonetti B, Bondy CA, Brenner M, et al. 1994. Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp. Neurol. 128:202-10
81. Cheng H-L, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman E L. 1996. Characterization of insulin-like growth factor-I and its receptor binding proteins in transected nerves and cultured Schwann cells. J. Neurochem. 66:525-36
82. Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Price DL. 1993. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10:359-67
83. Eckenstein F. 1988. Transient expression of NGF-receptor-like immunoreactivity in postnatal rat brain and spinal cord. Brain Res. 446:149-54
84. Ernfors P, Henschen A, Olson L, Persson H. 1989. Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron 2:1605-13
85. Kobayashi NR, Bedard AM, Hincke MT, Tetzlaff W. 1996. Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy. Eur. J. Neurosci. 8:1018-29
86. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, et al. 1993. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363:266-70
87. Oppenheim RW, Yin QW, Prevette D, Yan Q. 1992. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360:755-57
88. Yan Q, Elliott J, Snider WD. 1992. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360:753-55
89. Yan Q, Matheson C, Lopez OT, Miller JA. 1994. The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor. J. Neurosci. 14:5281-91
90. Watkins PJ. 1992. Clinical observations and experiments in diabetic neuropathy. Diabetologia 35:2-11
91. Hohn A, Leibrock J, Bailey K, Barde YA. 1990. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344:339-41
92. McMahon SB, Armanini MP, Ling L, Phillips HS. 1994. Expression and co-expression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12:1161-71
93. Gorin MD, Johnson EM. 1979. Experimental autoimmune model of nerve growth factor deprivation: effects on developing peripheral sympathetic and sensory neurons. Proc. Natl. Acad. Sci. USA 76:5382-86
94. Verge VMK, Merlio JP, Grondin J, Ernfors P, Persson H, et al. 1992. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J. Neurosci. 12:4011-22
95. Apfel SC, Lipton RB, Arezzo JC, Kessler JA. 1991. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol. 29:87-90
96. Apfel SC, Arezzo JC, Lipson LA, Kessler JA. 1992. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 31:76-80
97. Diamond J, Foerster A, Holmes M, Coughlin M. 1991. Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J. Neurosci. 12:1467-76
98. Diamond J, Holmes M, Coughlin M. 1991. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J. Neurosci. 12:1454-66
99. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. 1996. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2:703
100. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, et al. 1994. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:244-46
101. Lewin GR, Ritter AM, Mendell LM. 1993. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat J. Comp. Neurol. 13:2136-48
102. Falckh PH, Harkin LA, Head RJ. 1992. Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat. Clin. Exp. Pharmacol. Physiol. 19:541-45
103. Lonnerberg P, Soder O, Parvinen M, Ritzen EM, Persson H. 1992. Beta-nerve growth factor influences the expression of androgen-binding protein messenger ribonucleic acid in rat testis. Biol. Reprod. 47:381-88
104. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, et al. 1996. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85:345-56
105. Mazurek N, Weskamp G, Erne P, Otten U. 1986. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 198:29-43
106. Copray JCVM, Brouwer N. 1994. Selective expression of neurotrophin-3 messenger RNA in muscle spindles of the rat. Neuroscience 63:1125-35
107. Gao W-Q, Dybdal N, Shinsky N, Murnane A, Schmelzer C, et al. 1995. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann. Neurol. 38:30-37
108. Treanor JJS, Schmelzer C, Winslow JW, Nikolics K, Hefti F, Burton L E. 1995. Heterodimeric neurotrophins induce phosphorylation of trk receptors and promote neuronal differentiation. J. Biol. Chem. 270:23104-110
109. Urfer R, Tsoulfas P, Soppet D, Escandon E, Parada LF, Presta LG. 1994. The binding epitopes of neurotrophin-3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin. EMBO J. 13:5896-909
110. Agid Y. 1991. Parkinson's disease: pathophysiology. Lancet 337:1321-27
111. Knusel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, et al. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-dervived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA 88:961-65
112. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, et al. 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-33
113. Beck KD, Knusel B, Winslow JW, Rosenthal A, Burton LE. 1992. Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-pyridinium. Neurodegeneration 1:27-36
114. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59:99-106
115. Otto D, Unsicker K. 1993. FGF-2 mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. J. Neurosci. Res. 34:382-93
116. Knüsel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, et al. 1992. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12:4391-402
117. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, et al. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA 89:11347-51
118. Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F. 1993. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53:639-50
119. Ringstedt T, Lagercrantz H, Persson H. 1993. Expression of members of the trk family in the developing postnatal rat brain. Dev. Brain Res. 72:119-31
120. Poulsen KT, Armanini MP, Klein RD, Hynes MA, Phillips HS, Rosenthal A. 1994. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13:1245-52
121. Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, et al. 1993. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:401-12
122. Tomac A, Lindqvist E, Lin L-F H, Ögren SO. Young D, et al. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335
123. Beck KD, Valverde J, Poulsen K, Moffat B, Alexi T, et al. 1995. GDNF protects mesencephalic dopaminergic neurons from axotomy-induced degeneration in the adult brain. Nature 373:339-41
124. Sauer H, Rosenblad C, Bjorklund A. 1995. Glial cell line-derived neurotrophic factor but not transforming growth factor beta-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92:8935-39
125. Pichel JG, Shen L, Sheng HZ, Granholm A-C, Drago J, et al. 1996. Nature 382:73
126. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. 1996. Nature 382:70
127. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, et al. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76
128. Treanor JJS, Goodman L, De Sauvage F, Stone DM, Poulsen KT, et al. 1996. Nature 382:80
129. Trupp M, Arenas E, Fainzilber M, Nilsson A-S, Sieber B-A, et al. 1996. Nature 381:785
130. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, et al. 1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-64
131. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. 1995. Neuron 15:821-28
132. Sagot Y, Tan SA, Hammang JP, Aebischer P, Kato AC. 1996. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. Neuroscience 16:2335-41
133. Mount HTJ, Dean DO, Alberch J, Dreyfus CF, Black IB. 1995. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc. Natl. Acad. Sci. USA 92:9092-96
134. Arenas E, Trupp M, Åkerud P, Ibáñez CF. 1995. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15:1465-73
135. Hellmich HL, Kos L, Cho ES, Mahon KA, Zimmer A. 1996. Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech. Dev. 54:95-105
136. Suvanto P, Hiltunen JO, Arumäe U, Moshnyakow M, Sariola H, et al. 1996. Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur. J. Neurosci. 8:816-22
137. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. 1995. RET-deficient mice: an animal model for Hirschsprung's disease and renal agenesis. J. Int. Med. 238:327-32
138. Durbec PL, Larsson-Blomberg LB, Schuchardt A, Costantini F, Pachnis V. 1996. Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122:349-58
139. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RAE, Chui HC, et al. 1992. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann. Neurol. 32:625-32
140. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, et al. 1993. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330:15-31
141. Eagger SA, Levy R, Sahakian BJ. 1991. Tacrine in Alzheimer's disease. Lancet 337:989-94
142. Cacabelos R, Nordberg A, Caamaño J, Franco-Maside A, Fernández-Novoa L, et al. 1994. Molecular strategies for the first generations of antidementia drugs (I). Tacrine and related compounds. Drugs Today 30:295-337
143. Hefti F, Hartikka J, Knusel B. 1989. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging 10:515-33
144. Sofroniew MV. 1996. Nerve growth factor, ageing and Alzheimer's Disease. Alzheimer's Res 2:7-14
145. Hefti F, Dravid A, Hartikka J. 1984. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with septo-hippocampal lesions. Brain Res. 293:305-11
146. Fischer W, Wictorin K, Bjorklund A, Williams LR. Varon S, Gage FH. 1987. Amelioration of cholinergic neurons atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68
147. Will B, Hefti F. 1985. Behavioral and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions. Behav. Brain Res. 17:17-24
148. Markowska AL, Koliatsos VE, Breckler SJ, Price DL, Olton DS. 1994. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 14:4815-24
149. Venero JL, Hefti F. 1993. TrkA NGF receptor expression by non-cholinergic thalamic neurons. NeuroReport 4:959-62
150. Vazquez ME, Ebendahl T. 1991. Messenger RNAs for trk and the low-affinity NGF receptor in rat basal forebrain. NeuroReport 2:593-96
151. Hefti F, Venero JL, Widmer HR, Knusel B. 1995. Nerve growth factor therapy for Alzheimer's disease: comparison with brain-derived neurotrophic factor. In Research Advances in Alzheimer's Disease and Related Disorders, ed. K Iqbal, JA Mortimer, B Winblad, HM Wisniewski, pp. 321-28. New York: Wiley & Sons
152. Koliatsos VE, Price DL, Gouras GK, Cayouette MH, Burton LE, Winslow JW. 1994. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 on intact and injured basal forebrain. J. Comp. Neurol. 343:247-62
153. Fischer W, Sirevaag A, Wiegand SJ, Lindsay RM, Björklund A. 1994. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5, but not by brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 91:8607-11
154. Hefti F, Lapchak PA. 1993. Pharmacology of nerve growth factor in the brain. In Advances in Pharmacology, 24:239-73. Orlando: Academic
155. Olson L, Nordberg A, von Holst H, Backman L, Ebendahl T, et al. 1992. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient. J. Neurol. Transm. [P-D Sect] 4:79-95
156. Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Tuszynski MH, et al. 1995. Induction of Schwann cell hyperplasia in vivo after intracerebroventricular admiistration of nerve growth factor. Soc. Neurosci. Abstr. 21:119.1
157. Cummings BJ, Yee GJ, Cotman CW. 1992. bFGF promotes the survival of entorhinal layer II neurons after perforant path axotomy. Brain Res. 591:271-76
158. Peterson DA, Lucidi-Phillipi CA, Murphy DP, Ray J, Gage FH. 1996. Fibroblast growth factor-2 protects entorhinal layer II glutamatergic neurons from axotomy-induced death. J. Neurosci. 16:886-98
159. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, et al. 1993. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp. Neurol. 119:72-78
160. Clatterbuck RE, Price DL, Koliatsos VE. 1993. Ciliary neurotropic factor prevents retrograde neuronal death the adult central nervous system. Proc. Natl. Acad. Sci. USA 90:2222-26
161. Giehl KM, Tetzlaff W. 1996. BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur. J. Neurosci. 8:1167-75
162. Buttini M, Appel K, Sauter A, Gebicke-Haerter P-J, Boddeke HWGM. 1996. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71:1-16
163. Cheng B, Mattson MP. 1992. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1558-66
164. Shigeno T, Mima T, Takakura K, Graham DI, Kato G, et al. 1991. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:2914-19
165. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, et al. 1992. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182:593-99
166. Zhu CZ, Auer RN. 1994. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J. Cereb. Blood Flow Me tab. 14:237-42
167. Tsukahara T, Yonekawa MD, Tanaka K, Ohara O, Watanabe S, et al. 1994. The role of brain-derived neurotrophic factor in transient forebrain ischaemia in the rat brain. Neurosurgery 34:323
168. Chan K-M, Lam D-TN, Pong K, Widmer HR, Hefti F. 1996. Neurotrophin-4/5 treatment reduces infarct size in rats with middle cerebral artery occlusion. Neurochem. Res. 21:769-73
169. Yamada K, Kinoshita A, Kohmura E, Sakaguchi T, Taguchi J, et al. 1991. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J. Cereb. Blood Flow Metab. 11:472-78
170. Beck T, Lindholm D, Castrén E, Wree A. 1994. Brain-derived neurotrophic factor protects against ischaemic cell damage in rat hippocampus. J. Cereb. Blond Flow Metab. 14:689-92
171. Kawakami N, Kashiwagi S, Kitahara T, Yamashita T, Ito H. 1995. Effect of local administration of basic fibroblast growth factor against neuronal damage caused by transient intracerebral mass lesion in rats. Brain Res. 697:104-11
172. MacMillan V, Judge D, Wiseman A, Settles D, Swain J, Davis J. 1993. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage. Stroke 24:1735-39
173. Steinman L. 1996. Multiple sclerosis: a co-ordinated immunological attach against myelin in the central nervous system. Cell 85:299-302
174. Aizenman Y, Weischsel ME Jr, De Vellis J. 1986. Changes in insulin and transferrin requirements of pure brain neuronal cultures during embryonic development. Proc. Natl. Acad. Sci. USA 83:2263-66
175. Knusel B, Michel PP, Schwaber J, Hefti F. 1990. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, and the insulin-like growth factors. J. Neurosci. 10:558-70
176. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, et al. 1992. J. Neurobiol. 23:1221-30
177. Carson MJ, Behringer RR, Brinster RL, McMorris FA. 1993. Insulin-like growth factor increases brain growth and central nervous system myelination in transgenic mice. Neuron 10:729-40
178. Powell-Braxton L, Hollinghead P, Warbuton C, Dowd M, Pitts-Meek S, et al. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:2609-17
179. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. 1995. Mice homozygous for disrupted insulin-like growth factor I gene display reduced myelination in the CNS and reduced numbers of hippocampal granule and parvalbumin-containing neurons. Neuron 4:717-30
180. Yao DL, Liu X, Hudson LD, Webster HD. 1995. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 92:6190-94
181. Liu X, Yao D-L, Webster HdeF. 1995. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis. Multiple Sclerosis 1:2-9
182. Lassmann H, Suchanek G, Ozawa K. 1994. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann. Neurol. 36:S42-S46
183. Guan J, Skinner SJM, Beilharz EJ, Hua KM, Hodgkinson S, et al. 1996. The movement of IGF-1 into the brain parenchyma after hypoxic-ischaemic injury. NeuroReport 7:632-36
184. Tria MA, Fusco M, Vantini G, Mariot R. 1994. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp. Neurol. 127:178-83
185. Murakami T, Misaki M, Matsuda S, Higashi Y, Fuwa T, Yata N. 1994. Dose-dependent plasma clearance of human epidermal growth factor in rats. J. Pharmacol. Sci. 83:1400-15
186. Widmer HR, Ohsawa F, Knusel B, Hefti F. 1993. Down-regulation of phosphatidyl-inositol response to BDNF and NT-3 in cultures of cortical neurons. Brain Res. 614:325-34
187. Frank L, Ventimiglia R, Anderson K, Lindsay RM, Rudge JS. 1996. BDNF down-regulates neurotrophin responsiveness, trkB protein and trkB mRNA levels in cultured rat hippocampal neurons. Eur. J. Neurosci. 8:1220-30
188. Holtzman DM, Li Y, Parada L F, Kinsman S, Mobley WH, et al. 1992. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9:465-78
189. Knusel B, Kaplan DR, Hefti F. 1996. Intraparenchymal NGF injections in adult and aged rats induce long-lasting Trk tyrosine phosphorylation. Exp. Neurol. 139:121-30
190. Koliatsos VE, Clatterbuck RE, Nauta HJW, Knusel B, Burton LE, et al. 1991. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30:831-40
191. Lapchak PA, Araujo DM, Carswell S, Hefti F. 1993. Distribution of [125I]nerve growth factor in the rat brain following an intraventricular injection: sequestration by trkA mRNA expressing septal neurons. Neuroscience 54:445-60
192. Venero JL, Hefti F, Knusel B. 1996. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration. Mol. Pharm. 49:303-10
193. Pardridge WM. 1991. Transnasal and intraventricular delivery of drugs. In Peptide Drug Delivery to the Brain, ed. WM Pardridge, pp. 99-122. New York: Raven
194. Hoffman D, Wahlberg L, Aebischer P. 1990. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a Fimbria-Fornix lesion. Exp. Neurol. 110:39-44
195. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, et al. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373-76
196. Rosenberg MB, Friedmann T, Robertson RC, Tuszynksi M, Wolff JA, et al. 1988. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242:1575-78
197. Dekker AJ, Winkler J, Ray J, Thai LJ, Gage FH. 1994. Grafting of nerve growth factor-producing fibroblasts reduces behavioural deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 60:299-309
198. Martinez-Serrano A, Hantzopoulos PA, Björklund A. 1996. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. Eur. J. Neurosci. 8:727-35
199. Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH. 1994. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 126:1-4
200. Aebischer P, Winn SR, Tresco PA, Jaeger CB, Greene LA. 1991. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. J. Biomech. Eng. 113:178-83
201. Winn SR, Hammang JP, Emerich DF, Lee A, Palmiter RD, Baetge EE. 1994. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. USA 91:2324-28
202. Geschwind MD, Kessler JA, Geller AI, Federoff JH. 1994. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective Herpes Simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. Mol. Brain Res. 24:327-35
203. Ibanez CF. 1994. Structure-function relationships in the neurotrophin family. J. Neurobiol. 25:1349-61
204. Urfer R, Tsoulfas P, O'Connell L, Shelton DL, Parada LF, Presta LG. 1995. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J. 14:2795-805
205. Di Marco A, Gloaguen I, Graziani R, Paonessa G, Saggio I, et al. 1996. Identification of CNTF residues essential for LIF receptor binding and generation of CNTF receptor antagonists. Proc. Natl. Acad. Sci. USA 93:9247-52
206. Sohrabji F, Miranda RCG, Toran-Allerand CD. 1995. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92:11110-14
207. Murray KD, Wood PL, Rosasco C, Isackson PJ. 1996. A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrain. Neuroscience 70:617-30
208. Stone EA, Manavalan JS, Basham DA, Bing G. 1994. Effect of yohimbine on nerve growth factor mRNA and protein levels in rat hippocampus. Neurosci. Lett. 167:11-13
209. Fuji K, Hiramatsu M, Hayashi S, Kameyama T, Nabeshima T. 1993. Effects of propentofylline, an NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats. Neurosci. Lett. 150:99-102
210. Lapchak PA, Araujo DM, Hefti F. 1993. Systemic interleukin-1β decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 53:297-301
211. Katoh-Semba R, Semba R, Kashiwamata S, Kalo K. 1990. Influences of neonatal and adult exposures to testosterone on the levels of the beta-subunit of nerve growth factor in the neural tissues of mice. Brain Res. 522:112-17
212. Toran-Allerand CD, Miranda RC, Bentham WDL, Shrabji F, Brown TJ, et al. 1992. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA 89: 4668-72
213. McMillan PJ, Singer CA, Dorsa DM. 1996. The effects of ovariectomy and estrogen replacment on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 16:1860-65
214. Takeuchi R, Murase K, Furukawa Y, Furukawa S, Hayashi K. 1990. Stimulation of nerve growth factor synthesis/secretion by 1,4-benxoquinone and its derivatives in cultured mouse astroglial cells. FEBS Lett. 261:63-66
215. Carswell S, Hoffman EK, Clopton-Hartpence K, Wilcox HM, Lewis ME. 1992. Induction of NGFby isoproterenol, 4-methylcatechol and serum occurs by three distinct mechanisms. Mol. Brain Res. 15:145-50
216. Hanaoka Y, Takekazu O, Furukawa S, Furukawa Y, Hayashi K, Matsukura S. 1994. The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats. J. Neurol. Sci. 122:28-32
217. Kawagishi H, Ando M, Sakamoto H, Yoshida S, Ojima F, et al. 1991. Hericenones C, D and E, stimulators of nerve gorwth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett. 32:4561-64
218. Yamaguchi K, Sasano A, Urakami T, Tsuji T, Kondo K. 1993. Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci. Biotech. Biochem. 57:1231-33
219. Nita A, Murakami Y, Furukawa Y, Kawatsura W, Hayashi K, et al. 1994. Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:401-7
220. Paul JW, DaVanzo JP. 1992. 1,1,3 Tricyano-2-amino-1-propene (Triap) stimulates choline acetyltransferase activity in vitro and in vivo. Dev. Brain Res. 67:113-20
221. Fukuyama Y, Otoshi Y, Nakamura K, Kodama M, Nagasawa M, et al. 1992. Neutrophic sesquiterpene-neoligans from Magnolia obovata: structure and neurotrophic activity. Tetrahedron Lett. 48: 377-92
222. Kawagishi H, Shimada A, Shirai R, Okamoto K, Ojima F, et al. 1994. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 35:1569-72
223. Yamaguchi K, Uemura D, Tsuji T, Kondo K. 1994. Stimulation of nerve growth factor production by diterpenoids isolated from plants of Euphorbia species. Biosci. Biotech. Biochem. 58:1749-51
224. Pradines A, Magazin M, Schiltz P, Le Fur G, Caput D, Ferrara P. 1995. Evidence for nerve growth factor-potentiating activities of the non-peptidic compound SR 57746A in PC12 cells. J Neurochem. 64:1954-64
225. Koizumi S, Contreras ML, Matsuda Y, Hama T, Lazarovici P, Guroff G. 1988. K-252a: a specific inhibitor of the action of nerve growth factor on PC12 cells. J. Neurosci. 8:715-21
226. Knüsel B, Hefti F. 1992. K-252 compounds: modulators of neurotrophin signal transmission. J. Neurochem. 59:1987-96
227. Knüsel B, Kaplan DR, Winslow JW, Rosenthal A, Burton LE, et al. 1992. K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J. Neurochem. 59:715-22
228. Ohmichi M, Decker SJ, Pang L, Saltiel AR. 1992. Inhibition of the cellular actions of nerve growth factor by staurosporine and K-252a results from the attenuation of the activity of the trk tyrosine kinase. Biochemistry 31:4034-39
229. Saporito MS, Brown ER, Haun F, Miller M, Murakata C, et al. 1995. Comparison of the pharmacological actions of CEP1347 to nerve growth factor in rats with lesions of the nucleus basalis magnocellularis. Abstr. Soc. Neurosci. 25:112